The Novavax vaccine may finally be available to Americans soon, and one top vaccine expert believes it can help solve some issues health officials have faced during the vaccine rollout so far.
Dr Cody Meissner is the chief of pediatrics at Tufts Children’s Hospital in Boston Massachusetts and serves as a member of the Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC).
He told DailyMail.com that some people concerned about the novel nature and potential side-effects of the Pfizer-BioNTech and Moderna shots could be willing to receive the Novavax jab, which is a standard protein based vaccine.
Unlike the others, it also does not require hyper-cold storage with dry ice, which makes it easier and less costly to transport – a boon for…
Read the Full Article Here dailymail